Viemed Healthcare (VMD) Price to Earnings (2019 - 2026)

Viemed Healthcare (VMD) has reported Price to Earnings for 8 consecutive years, with 149.73 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Earnings rose 77.81% year-over-year to 149.73; the trailing twelve-month figure through Jun 2026 stood at 28.93 (up 51.07% YoY), and the FY2025 full-year result was 18.37, down 33.22% from the prior year.
• Price to Earnings grew to 149.73 in Q2 2026 per VMD's latest filing, from 131.88 in the prior quarter.
• Across five years, Price to Earnings topped out at 243.74 in Q1 2023 and bottomed at 48.57 in Q4 2025.
• Historically, Price to Earnings has averaged 131.99 across 5 years, with a median of 114.52 in 2022.
• The sharpest annual moves came in 2022 and 2023: Price to Earnings surged 133.04% in 2022, then sank 59.05% in 2023.
• Over 5 years, Price to Earnings stood at 117.99 in 2022, then retreated by 26.32% to 86.94 in 2023, then declined by 18.4% to 70.94 in 2024, then slumped by 31.54% to 48.57 in 2025, then soared by 208.27% to 149.73 in 2026.
• According to Business Quant data, Price to Earnings over the past three periods registered 149.73, 131.88, and 48.57 for Q2 2026, Q1 2026, and Q4 2025 respectively.